Aphria (NYSE:APHA) Stock Price Up 5.5%

Shares of Aphria Inc (NYSE:APHA) rose 5.5% during mid-day trading on Tuesday . The company traded as high as $6.96 and last traded at $6.92, approximately 4,539,074 shares traded hands during mid-day trading. A decline of 19% from the average daily volume of 5,601,579 shares. The stock had previously closed at $6.56.

APHA has been the subject of a number of analyst reports. Zacks Investment Research upgraded Aphria from a “hold” rating to a “buy” rating and set a $8.00 price target for the company in a research note on Wednesday, August 7th. Jefferies Financial Group initiated coverage on Aphria in a research note on Friday, May 24th. They issued a “buy” rating and a $11.00 price target for the company. CIBC lowered Aphria from a “neutral” rating to a “sector underperform” rating in a research note on Friday, July 26th. ValuEngine upgraded Aphria from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st. Finally, Clarus Securities initiated coverage on Aphria in a research note on Tuesday, April 16th. They issued a “buy” rating and a $22.75 price target for the company. One analyst has rated the stock with a sell rating, one has given a hold rating and seven have assigned a buy rating to the stock. Aphria presently has an average rating of “Buy” and an average target price of $13.63.

The company’s fifty day moving average price is $6.49. The company has a market capitalization of $1.65 billion, a price-to-earnings ratio of -62.91 and a beta of 3.07.

Aphria (NYSE:APHA) last released its quarterly earnings data on Thursday, August 1st. The company reported $0.05 EPS for the quarter, beating the consensus estimate of ($0.05) by $0.10. The company had revenue of $128.60 million for the quarter, compared to the consensus estimate of $99.26 million. Aphria’s revenue was up 971.7% on a year-over-year basis. As a group, equities research analysts anticipate that Aphria Inc will post 0.06 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Advisory Services Network LLC boosted its holdings in shares of Aphria by 45.3% during the 1st quarter. Advisory Services Network LLC now owns 5,625 shares of the company’s stock valued at $52,000 after purchasing an additional 1,755 shares during the last quarter. Synovus Financial Corp boosted its holdings in shares of Aphria by 56.9% during the 2nd quarter. Synovus Financial Corp now owns 5,514 shares of the company’s stock valued at $39,000 after purchasing an additional 2,000 shares during the last quarter. Shell Asset Management Co. boosted its holdings in shares of Aphria by 17.9% during the 1st quarter. Shell Asset Management Co. now owns 17,723 shares of the company’s stock valued at $165,000 after purchasing an additional 2,687 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Aphria by 76.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,248 shares of the company’s stock valued at $44,000 after purchasing an additional 2,698 shares during the last quarter. Finally, Creative Planning boosted its holdings in shares of Aphria by 6.4% during the 1st quarter. Creative Planning now owns 72,342 shares of the company’s stock valued at $674,000 after purchasing an additional 4,351 shares during the last quarter. 8.58% of the stock is owned by institutional investors and hedge funds.

Aphria Company Profile (NYSE:APHA)

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

Featured Article: What are the benefits of a portfolio tracker?

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.